BIOVENTUS INC. — Income Charts
26 quarters of history · ending 2026-03-28 · SEC EDGAR
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
BIOVENTUS INC. — SEC R-Report Segment ScorecardNEW
One card per operating segment. KPIs read the latest disclosed value (issuer-precomputed margin and YoY %, not recomputed client-side). Sparkline shows the 3-period revenue trend. Source: SEC EDGAR R-reports.
US
3-period revenue trend
International
3-period revenue trend
BIOVENTUS INC. — Revenue & Assets by GeographyNEW
Per-country / per-region revenue + long-lived non-current assets sourced from the issuer's 10-K dimensional XBRL on srt:StatementGeographicalAxis. Higher-level aggregates (Non Us) hidden to avoid double-counting.
United States
$248.2Mrev
Non Us
$30.8Mrev
BIOVENTUS INC. — Customer & Supplier ConcentrationNEW
Major-customer and supplier-side disclosures sourced from srt:MajorCustomersAxis dimensional XBRL. Coverage is ~44% of the S&P 500 (sparser than other panels) but high-value when present — a 20%+ single-counterparty exposure is a headline business risk required to be disclosed in 10-K MD&A under Reg S-K Item 101.Largest single-counterparty concentration this period: 28%.
Customer-Side Concentration
End-customer dependence — single-customer % of revenue. NVDA Customer 1 = 25%, AVGO Major Customer 1 = 32%.
As of 2025-12-31 · 1 row
| Counterparty | Kind | Concentration | Revenue / Spend |
|---|---|---|---|
| Customer 1 | customer | 28.1% | $64.5M |